AdvanSix Inc. (ASIX) Stock Price & Analysis
AdvanSix Inc. (ASIX) is trading at USD 15.67, down 0.06% today, as of October 23, 2026 at 16:16 UTC (US market open; quotes may be delayed), according to Nexqual market data.
ASIX last closed at USD 15.68; today's session has ranged USD 15.31–15.87 on volume of 100,000 shares. Market capitalization is $423.11M, with a 52-week range of USD 14.1–26.73 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 16:18 UTC.
Also available as compact Markdown for AI agents: nexqual.com/ASIX.md
Key facts (ASIX)
- Last four reported quarters (through Jun 30, 2026): revenue $1.56B, net income -$17.7M (-1.1% margin), free cash flow -$25.8M (SEC filings).
- Analysts: Hold (mean 2.50 on a 1–5 scale) (2 analysts), mean target USD 20 (range 18–22).
- Total return with dividends: 1Y -19.7% vs S&P 500 +14.7%; 5Y -63.8% vs S&P 500 +77.5%.
- Next earnings: 2026-11-04, EPS estimate USD -0.05, revenue estimate $426M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (ASIX)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $1.68B | $1.95B | $1.53B | $1.52B | $1.52B | $1.56B |
| Gross profit | $274M | $314M | $165M | $153M | $165M | — |
| Net income | $140M | $172M | $54.6M | $44.1M | $49.3M | -$17.7M |
| EPS (diluted) | $4.81 | $5.92 | $1.95 | $1.62 | $1.80 | — |
| Free cash flow | $162M | $184M | $10.2M | $1.7M | $6.4M | -$25.8M |
| Gross margin | 16.3% | 16.2% | 10.8% | 10.1% | 10.8% | — |
| Net margin | 8.3% | 8.8% | 3.6% | 2.9% | 3.2% | -1.1% |
| Revenue growth | +45.5% | +15.5% | -21.2% | -1.0% | +0.3% | — |
| Cash + short-term investments | $15.1M | $31.0M | $29.8M | $19.6M | $19.8M | — |
| Total debt | $135M | $115M | — | — | — | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (ASIX)
P/S 0.3x · P/B 0.5x · FCF yield -6.09% · Earnings yield -4.19% · Dividend yield (paid, TTM) 4.07% · Buyback yield (TTM) 0.36%
P/E at fiscal year-ends: Dec 2025 9.6x, Dec 2024 17.6x, Dec 2023 15.4x.
Analysts (ASIX)
Consensus Hold (mean 2.50 on a 1–5 scale), 2 analysts; mean target USD 20 (low 18, high 22).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-10 | Truist Securities | Target lowered | Hold | $20 → $18 |
Total return (dividends reinvested) (ASIX)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | -19.7% | -63.8% |
| S&P 500 (SPY) | +14.7% | +77.5% |
| Per year | -19.7% | -18.4% |
| Volatility (annualized) | 53.4% | 44.5% |
| Max drawdown | -40.0% (May 2026→Oct 2026) | -70.6% (Mar 2022→Nov 2025) |
ASIX revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Plant Nutrients | $131.4M | 31.2% | -16.2% |
| Chemical Intermediates | $127.0M | 30.1% | +18.3% |
| Nylon | $100.2M | 23.8% | +26.1% |
| Caprolactam | $62.6M | 14.9% | -5.7% |
| Total revenue | $421.3M | 100% | — |
ASIX revenue by region (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| United States | $354.3M | 84.1% | -1.2% |
| International | $67.0M | 15.9% | +30.4% |
| Total revenue | $421.3M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
ASIX suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | Shaw Industries Group | “Our largest customer is Shaw Industries Group Inc. ("Shaw"), one of the world's largest consumers of caprolactam and Nylon 6 resin.” |
Quoted from the company's 10-K filed Feb 20, 2026.
Companies that name ASIX in their SEC reports
| Relationship to ASIX | Company | Filing | Sentence |
|---|---|---|---|
| partner | CVR PARTNERS, LP (UAN) | 10-K Feb 18, 2026 | “The performance graph below compares the cumulative total return of the Partnership's common units to (a) the cumulative total return of the S&P 500 Composite Index and (b) a composite peer group ("Peer Group") consisting of CF Industries Holdings, Inc., LSB Industries, Inc., Nutrien Ltd., The Andersons, Inc., AdvanSix Inc., and Flotek Industries Inc. The graph assumes that the value of the investment in common un…” |
ASIX analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $-0.04 | $0.25 | -118.0% | $426.0M | 2 |
| Next quarter (ends Dec 2026) | $0.53 | $0.86 | -39.0% | $420.5M | 2 |
| Current fiscal year (ends Dec 2026) | $0.18 | $2.51 | -92.6% | $1.67B | 2 |
| Next fiscal year (ends Dec 2027) | $2.38 | $2.60 | -8.3% | $1.76B | 2 |
Key Statistics (as of October 23, 2026 at 16:18 UTC)
| Price | USD 15.67 |
|---|---|
| Change | ▼ 0.06% (down) |
| Previous Close | USD 15.68 |
| Open | USD 15.53 |
| Day Range | USD 15.31 – 15.87 |
| 52-Week Range | USD 14.1 – 26.73 |
| Volume | 100,000 shares |
| Market Cap | $423.11M |
| Exchange | NYQ |
Technical Analysis (ASIX)
Nexqual's technical model rates ASIX "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of October 23, 2026 at 16:18 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 38.39 (neutral) |
| vs SMA50 | Below (USD 16.49) |
| MACD | -0.25 (negative) |
Analyst Ratings (ASIX)
Wall Street analysts rate ASIX "Hold" based on 2 analysts, with a mean price target of USD 20 (range USD 18–22), per Nexqual as of October 23, 2026 at 16:18 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 20 |
| High Target | USD 22 |
| Low Target | USD 18 |
| Buy / Hold / Sell | 1 / 1 / 0 |
Earnings (ASIX)
| Next Earnings Date | 2026-11-04 |
|---|---|
| EPS Estimate | USD -0.05 |
| Revenue Estimate | $426.00M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.19 vs est 0.56 ▼ miss |
| 2026-03-31 | USD -0.5 vs est -0.48 ▼ miss |
| 2025-12-31 | USD 0.03 vs est -0.06 ▲ beat |
| 2025-09-30 | USD 0.08 vs est 0.4 ▼ miss |
Source: Nexqual, October 23, 2026 at 16:18 UTC.
Financials & Fundamentals (ASIX)
| Total Revenue | $1.56B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +2.70% |
| Gross Margin | +7.29% |
| Operating Margin | +2.15% |
| Profit Margin | -1.14% |
| ROE | -2.19% |
| Debt / Equity | 0.53 |
| Current Ratio | 1.28 |
| Total Cash | $7.22M |
| Total Debt | $423.94M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | -$25.75M (-1.7% of revenue) |
Source: Nexqual, October 23, 2026 at 16:18 UTC.
Financial Health Score (ASIX)
Nexqual rates AdvanSix Inc.'s overall financial health "Weak" across five dimensions, as of October 23, 2026 at 16:18 UTC.
| Growth | Mixed — Revenue +0.3% YoY (annual), slow |
|---|---|
| Profitability | Weak — Gross margin 7%, operating 2% (last 12 months) |
| Balance Sheet | Solid — $7M cash vs $424M debt |
| Cash Flow | Weak — FCF negative: -$26M (last 4 quarters to Jun 2026, SEC), burning cash |
| Efficiency | Critical — ROE -2%, ROA 0.5% |
Ownership (ASIX)
| Insider Ownership | +3.15% |
|---|---|
| Institutional Ownership | +94.14% |
| Shares Outstanding | 27.00M |
| Float | 24.50M |
| Short % of Float | +2.24% |
Source: Nexqual, October 23, 2026 at 16:18 UTC.
Leadership (ASIX)
AdvanSix Inc. is led by Erin N. Kane, CEO, President & Director, per Nexqual as of October 23, 2026 at 16:18 UTC.
| CEO, President & Director | Erin N. Kane |
|---|---|
| Vice President of Corporate Finance, Strategic Financial Planning & Analysis | Christopher Gramm |
| Senior VP & CFO | Patrick C. Day |
| Vice President, Controller, & Chief Accounting Officer | Rachael E. Ryan |
Major Backers & Investors (ASIX)
Notable institutional backers of AdvanSix Inc. include Castleknight Management LP, American Century Companies Inc, Aegis Financial Corporation, according to Nexqual as of October 23, 2026 at 16:18 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Castleknight Management LP | 5.89% |
| American Century Companies Inc | 5.05% |
| Aegis Financial Corporation | 4.48% |
| Aegis Funds-Aegis Value Fund | 3.43% |
| Alliancebernstein L.P. | 3.2% |
| AQR Capital Management, LLC | 2.59% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 9.04% |
| Dimensional Fund Advisors | 5.21% |
| Vanguard Group | 4.26% |
| Geode Capital | 2.56% |
Source: Nexqual, October 23, 2026 at 16:18 UTC.
From AdvanSix Inc.'s Latest SEC 10-K Filing (filed 2026-02-20)
Key Strengths & Strategy (as disclosed to the SEC)
- Our vertically integrated manufacturing facilities, scale, access to lower cost raw materials, and high plant utilization rates help us maintain our position as the world's lowest cost producer of caprolactam.
- First, we are vertically integrated into several key feedstock materials necessary to produce caprolactam, particularly phenol, ammonia and oleum/sulfuric acid, which we believe is a unique advantage in our industry.
- Our value chain of our five U.S.-based manufacturing facilities plays a critical role in global supply chains and enables us to innovate and deliver essential products for our customers across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets.
- We also manufacture sulfuric acid, ammonia and carbon dioxide as part of our integrated operations at Hopewell and occasionally sell any excess material not consumed internally to customers externally. •Chemical Intermediates – We manufacture, market and sell a number of chemical intermediate products that are derived from the manufacturing processes within our integrated supply chain.
Legal & Regulatory Risks (Item 1A, quoted)
- Failure to maintain effective internal controls could adversely impact our ability to meet our reporting requirements.
- Our spin-off could result in significant tax liability.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VHI | Valhi, Inc. | USD 13.96 | ▼ 2.62% |
| RYAM | Rayonier Advanced Materials Inc | USD 6.94 | ▲ 1.61% |
| BAK | Braskem SA | USD 1.65 | ▲ 3.12% |
| TROX | Tronox Holdings plc | USD 3.48 | ▼ 0.14% |
| LXU | LSB Industries, Inc. | USD 10.01 | ▲ 2.56% |
| WLKP | Westlake Chemical Partners LP | USD 20.9 | ▼ 0.29% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 16:18 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt